-
Product Insights
NewLikelihood of Approval Analysis for Cholestasis
Overview How likely is it that the drugs in Cholestasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cholestasis Overview Cholestasis is the slowing or stalling of bile flow from liver....
-
Product Insights
NewLikelihood of Approval Analysis for Diabetic Gastroparesis
Overview How likely is it that the drugs in Diabetic Gastroparesis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Gastroparesis Overview Gastroparesis is a long-term complication of diabetes that involves...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Adenocarcinoma of The Pancreas
Overview How likely is it that the drugs in Metastatic Adenocarcinoma of The Pancreas will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Adenocarcinoma of The Pancreas Overview Metastatic adenocarcinoma is...
-
Product Insights
NewLikelihood of Approval Analysis for Primary Immune Deficiency (PID)
Overview How likely is it that the drugs in Primary Immune Deficiency (PID) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Primary Immune Deficiency (PID) Overview Primary immune deficiency (PID) is...
-
Product Insights
NewLikelihood of Approval Analysis for Leiomyosarcoma
Overview How likely is it that the drugs in Leiomyosarcoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leiomyosarcoma Overview Leiomyosarcoma is an aggressive soft tissue sarcoma derived from smooth muscle...
-
Product Insights
NewLikelihood of Approval Analysis for Peanut Allergy
Overview How likely is it that the drugs in Peanut Allergy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peanut Allergy Overview Peanut allergy is common, especially in children. An allergic...
-
Product Insights
NewLikelihood of Approval Analysis for Cystic Fibrosis
Overview How likely is it that the drugs in Cystic Fibrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cystic Fibrosis Overview Cystic fibrosis (CF) is an inherited disease that causes...
-
Product Insights
NewLikelihood of Approval Analysis for Salivary Gland Cancer
Overview How likely is it that the drugs in Salivary Gland Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Salivary Gland Cancer Overview Salivary gland cancer refers to malignant tumors...
-
Product Insights
NewLikelihood of Approval Analysis for Esophageal Diseases
Overview How likely is it that the drugs in Esophageal Diseases will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Esophageal Diseases Overview Esophageal Diseases, which are characterized by weakened muscles and...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Ovarian Cancer
Overview How likely is it that the drugs in Metastatic Ovarian Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Ovarian Cancer Overview Metastatic ovarian cancer results from the spread...